Monica Ines

Monica Ines

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a post hoc analysis of an international survey.

Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a post hoc analysis of an international survey.

Journal: Frontiers in cardiovascular medicine

Published: March 18, 2025

Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan.

Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan.

Journal: ESC heart failure

Published: September 19, 2023

A plain language summary on preventing fungal infections with isavuconazole in people with blood-related conditions.

A plain language summary on preventing fungal infections with isavuconazole in people with blood-related conditions.

Journal: Future microbiology

Published: August 29, 2023

Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study.

Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study.

Journal: Frontiers in cardiovascular medicine

Published: June 12, 2023

Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms.

Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms.

Journal: European journal of heart failure

Published: October 14, 2022

Erratum for Earnshaw et al., "Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom".

Erratum for Earnshaw et al., "Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom".

Journal: Microbiology spectrum

Published: August 18, 2022

Effectiveness and safety of isavuconazole prophylaxis for invasive fungal infections in the haematologic setting.

Effectiveness and safety of isavuconazole prophylaxis for invasive fungal infections in the haematologic setting.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 10, 2022

Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom.

Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom.

Journal: Microbiology spectrum

Published: May 09, 2022

Matching-Adjusted Indirect Comparisons of Lorlatinib Versus Chemotherapy for Patients With Second-Line or Later Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer.

Matching-Adjusted Indirect Comparisons of Lorlatinib Versus Chemotherapy for Patients With Second-Line or Later Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 09, 2021

Societal costs and burden of hereditary transthyretin amyloidosis polyneuropathy.

Societal costs and burden of hereditary transthyretin amyloidosis polyneuropathy.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: December 20, 2019

Author response: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.

Author response: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.

Journal: Neurology

Published: July 31, 2019

Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.

Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.

Journal: Orphanet journal of rare diseases

Published: July 18, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026